A recent study of Wang et al. has shown that α-NETA, a CMKLR1 inhibitor, suppresses renal tumor cell development and lipid storage in ccRCC-derived xenograft models (XP296) and in the UOK101 cell line [21]. Here, CMKLR1 is linked to nonpapillary renal cell carcinoma.